A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 302 participants.
Also called NCT03884257
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 302 participants
- Sponsor
- Registry
-
NCT03884257
-
- Other papers using this trial's data
- Methodology of the BIOPACT RCT, a Multi-center, Randomized, Non-inferiority Trial Evaluating Safety and Efficacy of Passeo-18 Lux Drug-Coated Balloon (DCB) of Biotronik Compared to the Medtronic IN.PACT Admiral DCB in the Treatment of Subjects with Lesions of the Femoropopliteal Artery
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Austria, Belgium, France, Switzerland
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03884257. Randomized; single masking; primary purpose treatment. Start 2020-02-18 (actual); primary completion 2022-09-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.
- Acronym
- BIOPACT-RCT
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Passeo-18 Lux treatment group
- Intervention (Device)
- IN.PACT Admiral treatment group
- Lead sponsor
- KANDO Research
- Collaborator
- Xper Research
Record details
- Record id
cardio:ct-nct03884257- Content hash
8097b73bc07eb86dc3a0f17582e64fd657d9dc859dfeaa7bf1af363d28c71a21